Table 3.
Austria (n=86) | Switzerland (n=52) | |
Patients receiving at least one concomitant medication, n (%) | 31 (36.1) | 13 (25.0) |
Renin–angiotensin system agents | 7 (8.1) | 6 (11.5) |
Psychoanaleptics | 6 (7.0) | 2 (3.9) |
Beta-blocking agents | 4 (4.7) | 4 (7.7) |
Lipid-modifying agents | 4 (4.7) | 4 (7.7) |
Psycholeptics | 3 (3.5) | 0 |
Diabetes drugs | 3 (3.5) | 0 |
Analgesics | 0 | 3 (5.8) |
Drugs for acid-related disorders | 0 | 2 (3.9) |
Concomitant medications reported by anatomical main group.